[EDITOR'S NOTE: Subsequent to the publication of this issue, Dr. William J. Catalona did not assume the directorship of the Mellon Prostate Cancer Research Institute at U.Va.]
prostate cancer physician named to direct U.Va.'s new research
William J. Catalona, one of the nation's foremost prostate cancer
surgeons and researchers, has been named director of the Mellon
Prostate Cancer Research Institute at the U.Va.
is known for having determined that a simple blood test that measures
levels of prostate-specific antigen (PSA) is the most accurate
method for detecting prostate cancer, and for having helped develop
the free PSA test as a means of improving the accuracy of prostate
cancer screening. He also led national studies that gained FDA
approval of the blood tests.
Catalona's leadership of our center will allow us to develop one
of the nation's premier programs devoted to the cure of prostate
cancer," said Dr. Robert M. Carey, dean of the U.Va. School
of Medicine. The Mellon Institute was recently established
by a $20 million bequest from the estate of the late Paul Mellon,
a noted philanthropist who died of prostate cancer in 1999.
also is recognized as an expert in performing the "nerve-sparing"
radical prostatectomy that can preserve sexual potency. Currently,
he is conducting research in the genetics of prostate cancer.
His multi-institutional research group recently studied more than
200 brothers with prostate cancer, and found several new areas
in the human genome that may contain prostate cancer susceptibility
genes. Identification of prostate cancer genes may lead to new
tests for prostate cancer, as well as possible new means for treating
or preventing it.
graduate of Yale Medical School, Catalona trained in surgery at
the Yale New Haven Hospital, the University of California-San
Francisco, and the National Cancer Institute and in urology at
the Johns Hopkins Hospital. He has been on the faculty of the
Washington University School of Medicine in St. Louis, Mo., for
25 years, serving as chief of its urology division for 14 years.
author of more than 300 articles in scientific journals, books
and book chapters in medical texts, he also has a prostate cancer
information Web site.
Pending approval by the University's Board of Visitors, Catalona
is expected to assume his new position in several months.